Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$750K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
3 of 5 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 5 business days late.
The 9 most recent Form 4 transactions.
| $200K |
| Filing ↗ |
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Aug 3 | HEPA | Hepion Pharmaceuticals,… | PDBUY◆ | 2M | — | — | — | Open the original filing on SEC.gov |
| Aug 3 | HEPA | Hepion Pharmaceuticals,… | PDBUY◆ | 8M | — | — | — | Open the original filing on SEC.gov |
| Aug 3 | HEPA | Hepion Pharmaceuticals,… | PBUY | 2M | $0.05 | $100K | +14.0% | Open the original filing on SEC.gov |
| Aug 3 | HEPA | Hepion Pharmaceuticals,… | PBUY | 8M | $0.05 | $400K | +128.0% | Open the original filing on SEC.gov |
| Apr 21 | HEPA | Hepion Pharmaceuticals,… | PBUY | 1.3M | $0.04 | $50K | +25.0% | Open the original filing on SEC.gov |
| Apr 21 | HEPA | Hepion Pharmaceuticals,… | PBUY | 5M | $0.04 | $200K | — | Open the original filing on SEC.gov |
| Nov 3, 2025 | THAR | Tharimmune, Inc. | AGRANT◆ | 90,000 | — | — | — | Open the original filing on SEC.gov |